Moreover, Pfütze et al.[27] reported that rituximab therapy in 5 patients with mucosal PV induced excellent clinical responses which were associated with a significant reduction in prednisolone dosage and a decrease in anti-Dsg-specific IgG. The gene discussed is DSG1; the disease is acquired polycythemia vera.